JP2023527741A5 - - Google Patents
Info
- Publication number
- JP2023527741A5 JP2023527741A5 JP2022570279A JP2022570279A JP2023527741A5 JP 2023527741 A5 JP2023527741 A5 JP 2023527741A5 JP 2022570279 A JP2022570279 A JP 2022570279A JP 2022570279 A JP2022570279 A JP 2022570279A JP 2023527741 A5 JP2023527741 A5 JP 2023527741A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- use according
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063027194P | 2020-05-19 | 2020-05-19 | |
| US63/027,194 | 2020-05-19 | ||
| PCT/US2021/032808 WO2021236543A1 (en) | 2020-05-19 | 2021-05-17 | Treatment for amyloidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527741A JP2023527741A (ja) | 2023-06-30 |
| JP2023527741A5 true JP2023527741A5 (https=) | 2024-05-23 |
Family
ID=78708017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570279A Pending JP2023527741A (ja) | 2020-05-19 | 2021-05-17 | アミロイドーシスの治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230210846A1 (https=) |
| EP (1) | EP4138837A4 (https=) |
| JP (1) | JP2023527741A (https=) |
| KR (1) | KR20230013102A (https=) |
| CN (1) | CN116133661A (https=) |
| AU (1) | AU2021273731A1 (https=) |
| BR (1) | BR112022023486A2 (https=) |
| CA (1) | CA3183746A1 (https=) |
| IL (1) | IL298297A (https=) |
| MX (1) | MX2022014468A (https=) |
| TW (1) | TW202207931A (https=) |
| WO (1) | WO2021236543A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023114877A1 (en) * | 2021-12-15 | 2023-06-22 | Recurium Ip Holdings, Llc | Triple therapy combinations of bcl-2 inhibitors, wee-1 inhibitors and other chemotherapeutic agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200108301A (ko) * | 2018-01-10 | 2020-09-17 | 리커리엄 아이피 홀딩스, 엘엘씨 | 벤즈아미드 화합물 |
| WO2019199899A1 (en) * | 2018-04-09 | 2019-10-17 | Case Western Reserve University | Bioink and crosslinkable support medium for printing |
| US10659731B2 (en) * | 2018-04-10 | 2020-05-19 | Facebook, Inc. | Automated cinematic decisions based on descriptive models |
| CA3095513A1 (en) * | 2018-04-10 | 2019-10-17 | DDP Specialty Electronic Materials US, Inc. | Dispenser for can with fixed valve stem housing |
-
2021
- 2021-05-17 BR BR112022023486A patent/BR112022023486A2/pt not_active Application Discontinuation
- 2021-05-17 AU AU2021273731A patent/AU2021273731A1/en not_active Abandoned
- 2021-05-17 KR KR1020227044559A patent/KR20230013102A/ko not_active Withdrawn
- 2021-05-17 US US17/998,920 patent/US20230210846A1/en not_active Abandoned
- 2021-05-17 CN CN202180060027.8A patent/CN116133661A/zh active Pending
- 2021-05-17 WO PCT/US2021/032808 patent/WO2021236543A1/en not_active Ceased
- 2021-05-17 CA CA3183746A patent/CA3183746A1/en active Pending
- 2021-05-17 EP EP21807581.0A patent/EP4138837A4/en active Pending
- 2021-05-17 IL IL298297A patent/IL298297A/en unknown
- 2021-05-17 MX MX2022014468A patent/MX2022014468A/es unknown
- 2021-05-17 JP JP2022570279A patent/JP2023527741A/ja active Pending
- 2021-05-19 TW TW110118106A patent/TW202207931A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532889A5 (https=) | ||
| JP2023530166A5 (https=) | ||
| JP2013542990A5 (https=) | ||
| JP2023527741A5 (https=) | ||
| JP2008500987A5 (https=) | ||
| CA2569077C (en) | Combinations comprising antimuscarinic agents and corticosteroids | |
| JP2014510064A5 (https=) | ||
| JP2002525317A5 (https=) | ||
| EA201691126A1 (ru) | Находящаяся под давлением стабильная аэрозольная композиция комбинации гликопиррония бромида и формотерола в форме раствора | |
| JP6250542B2 (ja) | エクトインの治療的使用 | |
| JP2012528792A5 (https=) | ||
| RU2018103940A (ru) | Фармацевтические композиции, содержащие антагонист интегрина альфа4, для применения в лечении воспалительных состояний глаза | |
| HRP20180944T1 (hr) | Stabilan pripravak stlačene aerosolne otopine kombinacije glikopironijeva bromida i formoterola | |
| JP2015506983A5 (https=) | ||
| JP2024525567A5 (https=) | ||
| JP2006502160A5 (https=) | ||
| US5407926A (en) | Ophthalmic composition | |
| JPH11130679A5 (https=) | ||
| RU2015154037A (ru) | Применение антагониста рецептора NK-1 серлопитанта при зуде | |
| JP2019528316A5 (https=) | ||
| JP2021534201A5 (https=) | ||
| AR097078A1 (es) | Combinaciones que comprenden compuestos maba y corticosteroides, uso, kit y compuesto | |
| JP2006518382A5 (https=) | ||
| EP2701744A1 (en) | Combination therapy | |
| Pirker et al. | Angioedema and dysphagia caused by contact allergy to inhaled budesonide |